PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 20, 2026Journal of the American College of Cardiology6 citationsOpen Access

Atrial Mechanical Contraction Predicts Cerebrovascular Risk in Patients With Transthyretin Amyloid Cardiomyopathy and Sinus Rhythm

View Full Paper
APAldostefano PorcariBPBeatrice Dal PassoLVLucia Venneri

Key Points

  • To identify cerebrovascular risk in patients with transthyretin amyloid cardiomyopathy who are in sinus rhythm.
  • Analyzed 873 patients with ATTR-CM in sinus rhythm at the UK National Amyloidosis Centre.
  • Assessed left atrial function using speckle-tracking strain echocardiography.
  • Stratified patients according to left atrial strain contraction tertiles.
  • 269 patients (30.8%) developed incident atrial fibrillation over a median of 34 months.
  • 85 patients (9.7%) experienced a stroke or transient ischemic attack.
  • Left atrial dysfunction was linked to higher cerebrovascular events, particularly for patients with AEMD.

Abstract

Patients with transthyretin amyloid cardiomyopathy (ATTR-CM) remain at risk of cerebrovascular events even when in sinus rhythm (SR), yet the majority of these patients are unrecognized. This study sought to identify patients in SR at high risk of cerebrovascular events. We analyzed patients diagnosed with ATTR-CM between January 2003 and December 2023 at the UK National Amyloidosis Centre. Left atrial (LA) function was assessed using speckle-tracking strain echocardiography. Atrial electromechanical dissociation (AEMD) was defined as SR on electrocardiogram with absent left atrial strain contraction (LASc). Patients in SR were stratified according to LASc tertiles. The primary outcome was a cerebrovascular event defined as stroke or transient ischemic attack (TIA), whichever occurred first. The secondary outcome was development of atrial fibrillation (AF). Death was treated as a competing event. The study comprised 2,310 patients with ATTR-CM, of which 873 patients were in SR and not receiving anticoagulation (age 77 years, 82% male, 61% wild type, CHA 2 DS 2 -VASc 4). AEMD was present in 115 patients (13.2%). Of the patients in SR, over a median of 34 months (Q1-Q3: 18-54 months), 269 patients (30.8%) developed incident AF and 85 (9.7%) experienced stroke/TIA. Patients with baseline AF receiving anticoagulation had a rate of stroke or TIA of 0.7 per 100 person-years. AEMD was associated with a 2.4-fold higher incident AF and 3-fold higher risk of stroke or TIA compared with SR with LA mechanical contraction (8.7 vs 2.5 per 100 person-years, respectively, for stroke or TIA), independent of CHA 2 DS 2 -based scores and markers of disease severity. Among 758 patients in SR without AEMD, LASc tertiles (7%) exhibited an independent association with 1-year risk of stroke or TIA, with LASc 7%. This association was consistent after adjustment for NAC stage and prior cerebrovascular events. Adding LASc tertiles to CHA 2 DS 2 -VASc or CHA 2 DS 2 -VA significantly improved model fit and risk reclassification at 1 year. LA dysfunction, particularly AEMD and severely impaired LASc, is associated with increased cerebrovascular events in ATTR-CM. Using LAS analysis may refine risk stratification and help identify patients with ATTR-CM in SR who might potentially benefit from intensified extended rhythm monitoring or prophylactic anticoagulation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Porcari et al. (2026) studied this question.

synapsesocial.com/papers/6997b911baf9c852d8c25e6chttps://doi.org/10.1016/j.jacc.2025.12.033
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Markers of Left Atrial Myopathy: Prognostic Usefulness for Ischemic Stroke and Dementia in People in Sinus Rhythm2025 · 6 citations
  2. 2Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach2009 · 6,804 citations
  3. 3Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis2016 · 2,065 citations
  4. 4Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis2021 · 164 citations
  5. 5Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis2022 · 87 citations